ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 19.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $22,000 | -87.7% | 34,480 | -39.2% | 0.00% | – |
| Q3 2016 | $179,000 | +2.9% | 56,699 | +0.5% | 0.00% | -100.0% |
| Q2 2016 | $174,000 | +26.1% | 56,389 | +47.4% | 0.00% | – |
| Q1 2016 | $138,000 | -22.0% | 38,254 | +0.3% | 0.00% | -100.0% |
| Q4 2015 | $177,000 | -15.7% | 38,154 | +10.6% | 0.00% | 0.0% |
| Q3 2015 | $210,000 | -20.5% | 34,499 | +12.5% | 0.00% | 0.0% |
| Q2 2015 | $264,000 | – | 30,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 2,535,564 | $7,835,000 | 4.00% |
| ProQuest Associates IV LLC | 1,900,000 | $5,871,000 | 2.39% |
| Abingworth LLP | 437,994 | $1,349,000 | 1.41% |
| Hilltop Park Associates LLC | 75,000 | $232,000 | 0.97% |
| Broadfin Capital, LLC | 1,154,674 | $3,568,000 | 0.35% |
| Perceptive Advisors | 1,492,156 | $4,611,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $927,000 | 0.16% |
| Rock Springs Capital Management LP | 450,000 | $1,391,000 | 0.10% |
| WEXFORD CAPITAL LP | 145,622 | $450,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,960 | $49,000 | 0.02% |